🔴 Rocket Pharmaceuticals is trading 7.5% down in pre-market with no clear company-specific catalyst

Rocket Pharmaceuticals is trading 7.51% down at $3.21 after no clear company-specific catalyst emerged overnight.

• The latest company release was second-quarter 2026 results on August 10, not August 17.
• Recent coverage identified no specific news, while broader market conditions were generally firm.
• Because the market was modestly positive, macro sentiment does not clearly explain this decline.